| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 10.74 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Conventional anticancer approaches are often associated with severe side
effects. Herein, the authors assembled a novel nanoparticle whose therapeutic effect is triggered by laser
light. In in vitro assays, the produced nanomaterial was able to, after interacting with laser light, reduce
the viability of classic and advanced cancer models. In these conditions, but in the absence of laser light,
no cytotoxicity was observed. In this way, the on-demand effect (triggered by laser light) may contribute
to reduced side effects. Moreover, the produced nanoparticle revealed good stability, which is important
for its future translation.
Descrição
Palavras-chave
Cancer Photothermal therapy Poly(2-ethyl-2-oxazoline) Polymer–IR780 conjugate Spheroids
Contexto Educativo
Citação
Editora
Future medicine